Literature DB >> 11152509

Substrate sequence selection by retroviral integrase.

H Zhou1, G J Rainey, S K Wong, J M Coffin.   

Abstract

Integration of retrovirus DNA is a specific process catalyzed by the integrase protein acting to join the viral substrate DNA (att) sequences of about 10 bases at the ends of the long terminal repeat (LTR) to various sites in the host target cell DNA. Although the interaction is sequence specific, the att sequences of different retroviruses are largely unrelated to one another and usually differ between the two ends of the viral DNA. To define substrate sequence specificity, we designed an "in vitro evolution" scheme to select an optimal substrate sequence by competitive integration in vitro from a large pool of partially randomized substrates. Integrated substrates are enriched by PCR amplification and then regenerated and subjected to subsequent cycles of selection and enrichment. Using this approach, we obtained the optimal substrate sequence of 5'-ACGACAACA-3' for avian sarcoma-leukosis virus (ASLV) and 5'-AACA(A/C)AGCA-3' for human immunodeficiency virus type 1, which differed from those found at both ends of the viral DNA. Clonal analysis of the integration products showed that ASLV integrase can use a wide variety of substrate sequences in vitro, although the consensus sequence was identical to the selected sequence. By a competition assay, the selected nucleotide at position 4 improved the in vitro integration efficiency over that of the wild-type sequence. Viral mutants bearing the optimal sequence replicated at wild-type levels, with the exception of some mutations disrupting the U5 RNA secondary structure important for reverse transcription, which were significantly impaired. Thus, maximizing the efficiency of integration may not be of major importance for efficient retrovirus replication.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11152509      PMCID: PMC114042          DOI: 10.1128/JVI.75.3.1359-1370.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases.

Authors:  J Kulkosky; K S Jones; R A Katz; J P Mack; A M Skalka
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

2.  Interaction between retroviral U5 RNA and the T psi C loop of the tRNA(Trp) primer is required for efficient initiation of reverse transcription.

Authors:  A Aiyar; D Cobrinik; Z Ge; H J Kung; J Leis
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

3.  Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus.

Authors:  S A Chow; K A Vincent; V Ellison; P O Brown
Journal:  Science       Date:  1992-02-07       Impact factor: 47.728

4.  HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer.

Authors:  A Engelman; K Mizuuchi; R Craigie
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

5.  Human immunodeficiency virus integrase protein requires a subterminal position of its viral DNA recognition sequence for efficient cleavage.

Authors:  C Vink; D C van Gent; Y Elgersma; R H Plasterk
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

6.  Structure-based mutagenesis of the human immunodeficiency virus type 1 DNA attachment site: effects on integration and cDNA synthesis.

Authors:  H E Brown; H Chen; A Engelman
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

7.  Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA.

Authors:  F D Bushman; R Craigie
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

8.  Both substrate and target oligonucleotide sequences affect in vitro integration mediated by human immunodeficiency virus type 1 integrase protein produced in Saccharomyces cerevisiae.

Authors:  A D Leavitt; R B Rose; H E Varmus
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

9.  Human immunodeficiency virus type 1 integration protein: DNA sequence requirements for cleaving and joining reactions.

Authors:  P A Sherman; M L Dickson; J A Fyfe
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

10.  Substrate specificity of recombinant human immunodeficiency virus integrase protein.

Authors:  R L LaFemina; P L Callahan; M G Cordingley
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

View more
  13 in total

1.  DNase protection analysis of retrovirus integrase at the viral DNA ends for full-site integration in vitro.

Authors:  A Vora; D P Grandgenett
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Multiple modifications allow high-titer production of retroviral vectors carrying heterologous regulatory elements.

Authors:  Juraj Hlavaty; Anika Stracke; Dieter Klein; Brian Salmons; Walter H Günzburg; Matthias Renner
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

3.  In vitro targeting of strand transfer by the Ty3 retroelement integrase.

Authors:  Xiaojie Qi; Suzanne Sandmeyer
Journal:  J Biol Chem       Date:  2012-04-04       Impact factor: 5.157

4.  Differential assembly of Rous sarcoma virus tetrameric and octameric intasomes is regulated by the C-terminal domain and tail region of integrase.

Authors:  Sibes Bera; Krishan K Pandey; Hideki Aihara; Duane P Grandgenett
Journal:  J Biol Chem       Date:  2018-09-05       Impact factor: 5.157

5.  Strain-specific effect on biphasic DNA binding by HIV-1 integrase.

Authors:  Kyle J Hill; Leonard C Rogers; Duncan T Njenda; Donald H Burke; Stefan G Sarafianos; Anders Sönnerborg; Ujjwal Neogi; Kamalendra Singh
Journal:  AIDS       Date:  2019-03-01       Impact factor: 4.177

6.  HIV-1 integrase interaction with U3 and U5 terminal sequences in vitro defined using substrates with random sequences.

Authors:  Elena Brin; Jonathan Leis
Journal:  J Biol Chem       Date:  2002-03-15       Impact factor: 5.157

7.  Mutations in the U5 region adjacent to the primer binding site affect tRNA cleavage by human immunodeficiency virus type 1 reverse transcriptase in vivo.

Authors:  Jangsuk Oh; Mary Jane McWilliams; John G Julias; Stephen H Hughes
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

8.  Rous sarcoma virus (RSV) integration in vivo: a CA dinucleotide is not required in U3, and RSV linear DNA does not autointegrate.

Authors:  Jangsuk Oh; Kevin W Chang; Rafal Wierzchoslawski; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

9.  Molecular and genetic determinants of rous sarcoma virus integrase for concerted DNA integration.

Authors:  Roger Chiu; Duane P Grandgenett
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  A possible role for the asymmetric C-terminal domain dimer of Rous sarcoma virus integrase in viral DNA binding.

Authors:  Ke Shi; Krishan K Pandey; Sibes Bera; Ajaykumar C Vora; Duane P Grandgenett; Hideki Aihara
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.